Effects of soy isoflavone supplementation on patients with diabetic nephropathy: a systematic review and meta-analysis of randomized controlled trials-Reference-Cited by-同舟云学术

Effects of soy isoflavone supplementation on patients with diabetic nephropathy: a systematic review and meta-analysis of randomized controlled trials

Published:2021 Issue:17 Volume:12 Page:7607-7618
ISSN:2042-6496
Container-title:Food & Function
language:en
Short-container-title:Food Funct.

Author:

Wang Xue¹,Liang Qing-Feng¹,Zeng Xia¹,Huang Guang-Xiao¹,Xin Gui-Zhong²,Xu You-Hua³,Wang Shu-Mei¹,Tang Dan¹^ORCID

Affiliation:

1. Key Laboratory of Digital Quality Evaluation of Chinese Materia Medica of State Administration of TCM and Engineering & Technology Research Center for Chinese Materia Medica Quality of Guangdong Province, Guangdong Pharmaceutical University, Guangzhou 510006, China

2. State Key Laboratory of Natural Medicines, Department of Chinese Medicines Analysis, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 210009, China

3. State Key Laboratory of Quality Research in Chinese Medicine, Faculty of Chinese Medicine, Macau University of Science and Technology, Macau, China

Abstract

Soy isoflavones have been widely used as a source of functional foods. The results of our study showed that soy isoflavone intake is effective in ameliorating diabetic nephropathy.

Funder

National Natural Science Foundation of China

National Science and Technology Major Project

Guangzhou Municipal Science and Technology Project

Publisher

Royal Society of Chemistry (RSC)

Subject

General Medicine,Food Science

Link

http://pubs.rsc.org/en/content/articlepdf/2021/FO/D1FO01175H

Reference56 articles.

1. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition